欧洲分子诊断市场预测至 2030 年 - 区域分析 - 按疾病领域（肿瘤、传染病、基因检测、心脏病、免疫系统疾病等）、技术（聚合酶链式反应、等温核酸扩增技术、DNA 测序等） - 世代测序、DNA 微阵列、原位杂交等）、产品和服务（检测和试剂盒、仪器以及服务和软件）以及最终用户（医院和诊所、诊断实验室、研究和学术机构等） ）
No. of Pages: 134 | Report Code: TIPRE00026715 | Category: Life Sciences
No. of Pages: 134 | Report Code: TIPRE00026715 | Category: Life Sciences
分子诊断程序可用于检测多种疾病，例如肿瘤学疾病、传染病、心脏病和免疫系统疾病；它们还可以用于基因测试，使用 DNA 和 RNA 等遗传物质来诊断不同的疾病。癌症是全世界死亡的主要原因之一。及早发现这种疾病有助于防止患者死亡。根据 UK.GOV 2021 年 11 月 22 日发布的数据，COVID-19 的感染率为每 10 万人中约 422.7 人。因此，目标疾病患病率的上升推动了分子诊断市场的增长。
欧洲分子诊断市场细分为德国、英国、法国、意大利、西班牙和欧洲其他国家。该地区在全球分子诊断市场中占有重要份额，预计 2022 年至 2030 年复合年增长率将强劲。欧洲市场的增长归因于生命科学研究的不断发展以及政府对传染病检测投资的增加。
慢性阻塞性肺疾病 (COPD)、糖尿病、癌症和关节炎等慢性疾病可以通过如果不及时治疗，将危及生命。例如，慢性淋巴细胞白血病（CLL）是德国最常见的白血病类型。据德国《德国报》报道，德国 CLL 的患病率约为每 10 万人中 6 例；每年有近 850 名女性和 1,000 名男性死于 CLL。
欧洲分子诊断市场细分为疾病领域、技术、产品和服务、最终用户和国家。
基于疾病欧洲分子诊断市场细分为传染病、肿瘤学、基因检测、心脏病、免疫系统疾病等。 2022年，传染病领域的欧洲分子诊断市场份额最大。
根据技术，欧洲分子诊断市场细分为聚合酶链反应（PCR）、原位杂交、等温核酸扩增技术(INAAT)、DNA 测序和下一代测序 (NGS)、DNA 微阵列等。聚合酶链式反应 (PCR) 细分市场将于 2022 年占据欧洲最大的分子诊断市场份额。聚合酶链式反应 (PCR) 进一步细分为 RT-PCR、qPCR、多重 PCR 等。
根据产品和服务，欧洲分子诊断市场分为检测和试剂盒、仪器、服务和软件。 2022 年，检测和试剂盒领域在欧洲分子诊断市场份额中占据最大份额。
根据最终用户，欧洲分子诊断市场分为诊断实验室、医院和诊所、研究和学术机构等。到2022年，诊断实验室领域将占据欧洲最大的分子诊断市场份额。
根据国家/地区，欧洲分子诊断市场分为德国、英国、法国、意大利、西班牙和其他国家/地区欧洲。德国将在 2022 年主导欧洲分子诊断市场。
雅培实验室、安捷伦科技公司、赛默飞世尔科技公司、F. Hoffmann-La Roche Ltd、Qiagen NV、bioMerieux SA、Illumina Inc、丹纳赫、西门子 Healthineers AG 和诺华公司是欧洲分子诊断市场上的一些领先公司。
Strategic insights for Europe Molecular Diagnostics involve closely monitoring industry trends, consumer behaviours, and competitor actions to identify opportunities for growth. By leveraging data analytics, businesses can anticipate market shifts and make informed decisions that align with evolving customer needs. Understanding these dynamics helps companies adjust their strategies proactively, enhance customer engagement, and strengthen their competitive edge. Building strong relationships with stakeholders and staying agile in response to changes ensures long-term success in any market.
| Report Attribute | Details |
|---|---|
| Market size in 2022 | US$ 4,592.54 Million |
| Market Size by 2030 | US$ 11,225.77 Million |
| Global CAGR (2022 - 2030) | 11.8% |
| Historical Data | 2020-2021 |
| Forecast period | 2023-2030 |
| Segments Covered |
By 疾病领域
|
| Regions and Countries Covered | 欧洲
|
| Market leaders and key company profiles |
The regional scope of Europe Molecular Diagnostics refers to the geographical area in which a business operates and competes. Understanding regional nuances, such as local consumer preferences, economic conditions, and regulatory environments, is crucial for tailoring strategies to specific markets. Businesses can expand their reach by identifying underserved regions or adapting their offerings to meet regional demands. A clear regional focus allows for more effective resource allocation, targeted marketing, and better positioning against local competitors, ultimately driving growth in those specific areas.
The Europe Molecular Diagnostics Market is valued at US$ 4,592.54 Million in 2022, it is projected to reach US$ 11,225.77 Million by 2030.
As per our report Europe Molecular Diagnostics Market, the market size is valued at US$ 4,592.54 Million in 2022, projecting it to reach US$ 11,225.77 Million by 2030. This translates to a CAGR of approximately 11.8% during the forecast period.
The Europe Molecular Diagnostics Market report typically cover these key segments-
The historic period, base year, and forecast period can vary slightly depending on the specific market research report. However, for the Europe Molecular Diagnostics Market report:
The Europe Molecular Diagnostics Market is populated by several key players, each contributing to its growth and innovation. Some of the major players include:
The Europe Molecular Diagnostics Market report is valuable for diverse stakeholders, including:
Essentially, anyone involved in or considering involvement in the Europe Molecular Diagnostics Market value chain can benefit from the information contained in a comprehensive market report.
Office No. 1011, First floor, Farena Corporate Park, Magarpatta-Mundhwa road, Pune - 411028, Maharashtra, India
UK+442030260021, US:+16467917070
sales@businessmarketinsights.com
Get Free Sample For Europe Molecular Diagnostics Market
